FIFA, June 6 (Xinhua)-- the US Food and Drug Administration (FDA) is relaxing regulations on the import of certain chemotherapeutic drugs to address the shortage of anticancer drugs. The agency said it would allow Qilu Pharmaceuticals, a Chinese drugmaker, to ship a chemotherapy injection called cisplatin to the US, although the product had not yet been approved by the FDA and the bottle was labeled in Chinese. This is the first time that a Chinese pharmaceutical company has made a shortage of drugs to the United States with products on sale in the domestic market. (daily Economic News)